Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Dec;165(12):819-29.
doi: 10.1007/s00431-006-0189-x. Epub 2006 Jun 29.

Population clinical pharmacology of children: modelling covariate effects

Brian J Anderson  1 , Karel Allegaert, Nicholas H G Holford
Affiliations
Review

Population clinical pharmacology of children: modelling covariate effects

Brian J Anderson et al. Eur J Pediatr. 2006 Dec.

Abstract

Introduction: Population modelling using mixed effects models provides a means to study variability in paediatric drug responses among individuals representative of those in whom the drug will be used clinically.

Discussions: Explanatory covariates explain the predictable part of the between-individual variability. Growth and development are two major aspects of children not seen in adults. These aspects can be investigated by using size and age as covariates. Problems attributable to co-linearity can be approached by using size as the first covariate. Size standardisation is achieved using allometric scaling, a mechanistic approach that has a strong theoretical and empirical basis. Age is used to describe the maturation of clearance. The quantitative models (linear, exponential, first-order, variable slope sigmoidal) used to describe this maturation process vary depending on the span of the ages under investigation. Measures of response are not always straightforward and can be more difficult to quantify in children.

Conclusion: Covariate investigation in children is improving the understanding of developmental aspects of drug disposition and effects in the paediatric population, ultimately leading to more effective use of medications.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Paediatr Anaesth. 2005 Apr;15(4):282-92 - PubMed
    1. Nutrition. 1989 Sep-Oct;5(5):303-11; discussion 312-3 - PubMed
    1. J Pharmacokinet Biopharm. 1998 Oct;26(5):559-79 - PubMed
    1. Antimicrob Agents Chemother. 2004 Apr;48(4):1159-67 - PubMed
    1. Br J Anaesth. 2005 Aug;95(2):231-9 - PubMed

Publication types

LinkOut - more resources